ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1994

Helicobacter Pylori Infection Among Korean Patients with Rheumatoid Arthritis and Its Interaction with Shared Epitope

Eun Ha Kang1, So-Young Bang 2, Ye Ji Lee 3, You-Jung Ha 1, Yun Jong Lee 4, Yeong-Wook Song 3, Sang-Cheol Bae 2 and Eun Bong Lee 5, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea, Seongnam, Republic of Korea, 2Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 3Seoul National University Hospital, Seoul, Republic of Korea, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea, 5Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, seoul

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: rheumatoid arthritis (RA) and pathogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: While smoking is an important environmental risk factor for rheumatoid arthritis (RA) development, only a small proportion of Korean patients with RA were found to have tobacco exposure. Since Helicobacter pylori (HP) infection is not only highly prevalent among Korean adult population but also causes chronic gastric inflammation, we aimed to test potential interaction between shared epitope (SE) and HP infection for the risk of anti-citrullinated protein antibody (ACPA)-positive RA in a Korean population.

Methods: SE distribution and HP infection status were compared between ACPA-positive patients (n=202 for cases) who met 1987 ACR classification criteria for RA and age- and sex-matched healthy controls (n=187 for controls). SE was considered positive for HLA-DRB1*01:01, *01:02, *04:01, *04:04, *04:05, *04:08, *04:10, *10:01, *14:02, and *14:06. HP infection was assessed by ELISA based anti-HP IgG titers (cut-off value of 20 U/mL). Logistic regression analysis was used to estimate the odds ratio (OR) and 95% confidence interval (CI). The relative excess risk due to interaction (RERI) based on OR was estimated to assess additive interaction.

Results: Patients with RA showed a mean (standard deviation, SD) age of 41 (11.7) years with 63.3% female. The anti-HP IgG titer was significantly higher among RA patients than controls (mean±SD, 6832±6406 vs. 3539±5238, p < 0.0001). RA patients showed a higher prevalence of HP infection and SE than controls (90.1% vs. 75.9%, p < 0.0001 for HP infection; 75.2% vs. 35.1%, p < 0.0001 for SE). SE and HP infection were independently associated with RA, adjusting for age and sex (Table 1, Model 1). The magnitude of association between HP infection and RA was similar between SE carriers (2.63 [1.17-5.88]) and non-carriers (2.72 [0.90-8.47], adjusting for age and sex. We found no multiplicative interaction between HP infection and SE for the risk of RA (measure of interaction [95% CI] = 1.05 [0.27-4.15, p = 0.94) (Table 1, Model 2). Although the additive interaction was positive (RERIOR [95% CI] = 9.87 [-3.73-23.48], p = 0.15), it was not statistically significant possibly due to limited power.

Conclusion: There was a significant association between RA and HP infection independent of SE status. We found no multiplicative interaction but positive, albeit statistically not significant, additive interaction between HP infection and SE for the risk of RA. Whether the association derives from causal relationship or merely suggests a higher susceptibility towards HP infection among RA patients remains to be determined.

Table 1. Association between rheumatoid arthritis and shared epitope -SE- or Helicobacter pylori -HP- infection


Disclosure: E. Kang, Seoul National University Bundang Hospital, 3; S. Bang, Hanyang University, 3; Y. Lee, None; Y. Ha, Seoul National University Bundang Hospital, 3; Y. Lee, Seoul National University Bundang Hospital, 3; Y. Song, Astellas Pharma, Inc., 9; S. Bae, None; E. Lee, Seoul National University Hospital, 3.

To cite this abstract in AMA style:

Kang E, Bang S, Lee Y, Ha Y, Lee Y, Song Y, Bae S, Lee E. Helicobacter Pylori Infection Among Korean Patients with Rheumatoid Arthritis and Its Interaction with Shared Epitope [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/helicobacter-pylori-infection-among-korean-patients-with-rheumatoid-arthritis-and-its-interaction-with-shared-epitope/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/helicobacter-pylori-infection-among-korean-patients-with-rheumatoid-arthritis-and-its-interaction-with-shared-epitope/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology